Crohn Disease: all 1,923 studies
Page 17 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.
- Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination TherapyCompletedNCT01698307Phase 4
- Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's DiseaseCompletedNCT01697761Not applicable
- Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRICompletedNCT01696838Not applicable
- Bioavailability of Vitamin D in Children and Adolescents With Crohn's DiseaseCompletedNCT01692808Phase 2
- FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)CompletedNCT01676324
- Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)WithdrawnNCT01674413Phase 3
- Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn DiseaseTerminatedNCT01671579Not applicable
- Ultrasound Stiffness Imaging in Crohn's DiseaseCompletedNCT01666626
- Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGMCompletedNCT01663142
- Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α TherapyCompletedNCT01661257Phase 3
- A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.CompletedNCT01659762Phase 1
- Single Incision Laparoscopic Surgery in Treating Patients With Colorectal DiseaseCompletedNCT01656746Not applicable
- Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's DiseaseWithdrawnNCT01647412Phase 2
- A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's DiseaseWithdrawnNCT01635621Phase 2
- Investigation of Sexual Function in Crohn's Disease Patients With Perianal FistulasWithdrawnNCT01635543
- A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's DiseaseStatus unknownNCT01632462Phase 4
- Adalimumab for the Management of Post-operative Crohn's Disease (CD)Status unknownNCT01629628Phase 3
- Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's DiseaseCompletedNCT01624376Phase 2
- Energy Expenditure in Patients With Crohn's DiseaseStatus unknownNCT01622270
- Japanese Phase I of GSK1605786CompletedNCT01611805Phase 1
- Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's DiseaseCompletedNCT01596894Phase 4
- Comparative Effectiveness of MR EnterographyCompletedNCT01593462Not applicable
- EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB TreatmentTerminatedNCT01582568
- Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)TerminatedNCT01577264
- Psychology of Crohn's DiseaseCompletedNCT01573078
- Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's DiseaseTerminatedNCT01569503Phase 3
- Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s DiseaseCompletedNCT01564823Phase 3
- Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With ImmunosuppressantsTerminatedNCT01562951Phase 3
- Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn DiseaseStatus unknownNCT01559142Phase 3
- Adalimumab-psoriasis and Small Bowel LesionsCompletedNCT01556672Phase 4
- Assessment of Capsule Endoscopy Scoring Index (CESI), Harvey-Bradshaw Index (HBI) and Biological Markers in Small Bowel Crohn's Disease (SBCD)CompletedNCT01555437
- Clinical Course of Korean Crohn's Disease CohortStatus unknownNCT01554007
- The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's DiseaseStatus unknownNCT01548014Phase 3
- CAre of Patients With PArenteral Nutrition At HomeCompletedNCT01545063
- Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's DiseaseCompletedNCT01541579Phase 3
- Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's DiseaseCompletedNCT01540942Not applicable
- Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune DisordersTerminatedNCT01540292Phase 1/2
- Improving Medication Adherence in Pediatric Inflammatory Bowel DiseaseCompletedNCT01536509Not applicable
- Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD)WithdrawnNCT01524120
- L-carnitine to Treat Fatigue Associated With Crohn's DiseaseWithdrawnNCT01523106Not applicable
- Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.CompletedNCT01517516
- Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's DiseaseNo longer availableNCT01510431
- Efficacy Study of Pneumococcal Vaccination in Crohn's DiseaseCompletedNCT01505855Phase 4
- Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's DiseaseStatus unknownNCT01503099
- Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)CompletedNCT01496053Phase 2/3
- A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult SubjectsCompletedNCT01489943Phase 1
- Prebiotic Effect on Metabolites in Crohn's DiseaseCompletedNCT01487759Not applicable
- Prognostic Indicators as Provided by the EPIC ClearViewCompletedNCT01476995
- Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel DiseaseCompletedNCT01473927
- Disease Course in an IBD Cohort in the Era of Biological TreatmentCompletedNCT01468090
- Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's DiseaseCompletedNCT01466374Phase 2
- Study Investigating Tailored Treatment With Infliximab for Active Crohn's DiseaseCompletedNCT01442025Phase 4
- Open Label Extension Study to Protocol C2/13/DR-6MP-02WithdrawnNCT01433432Phase 2
- Endomicroscopy in IBD PatientsCompletedNCT01417728
- Endomicroscopy for Assessment of Mucosal HealingCompletedNCT01417715
- Endoscopy for Assessment of Mucosal Healing in IBDCompletedNCT01417702
- Exacerbating Factors in Inflammatory Bowel DiseaseCompletedNCT01405105
- Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's DiseaseCompletedNCT01392365
- A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's DiseaseTerminatedNCT01388933Phase 2
- Anal Crohn Fistula SurgeryStatus unknownNCT01388257Not applicable
- Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's DiseaseTerminatedNCT01378390Phase 3
- Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.CompletedNCT01372969Phase 1/2
- Vitamin D Supplementation in Adult Crohn's DiseaseCompletedNCT01369667Phase 4
- Contrast Ultrasound of the Small Intestine in Patients With Crohns DiseaseCompletedNCT01365767
- Retrospective Data Analysis in Crohn's DiseaseCompletedNCT01363427
- A Phase II Efficacy Study in Fistulizing Crohn's Disease PatientsCompletedNCT01355614Phase 2
- Adherence to Mesalamine Profile for Patients With Inflammatory Bowel DiseaseCompletedNCT01349504
- Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)CompletedNCT01346826Phase 4
- A Study of TRK-170 for the Treatment of Crohn's DiseaseCompletedNCT01345799Phase 2
- Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsCompletedNCT01341808Phase 4
- Switching From Adalimumab to InfliximabCompletedNCT01338740
- Mesalamine and Reproductive Health StudyCompletedNCT01331551
- A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's DiseaseCompletedNCT01316601Phase 2
- Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's FistulaCompletedNCT01314079
- Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression AnastomosisCompletedNCT01301417
- Bronchial Hyperreactivity in Children With Crohn DiseaseCompletedNCT01297907
- Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)WithdrawnNCT01293656
- Clinical Efficacy of TNFa Kinoid in Crohn's Disease PatientsCompletedNCT01291810Phase 2
- Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.CompletedNCT01290042Phase 1
- Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)CompletedNCT01289366
- Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's DiseaseCompletedNCT01279577Phase 2
- Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the GutCompletedNCT01275508Phase 1/2
- Infliximab, Regulatory T Cells, IL2 and Crohn's DiseaseWithdrawnNCT01266785Not applicable
- The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular EndoscopyStatus unknownNCT01266629
- Drug-Disease Interaction in Crohn's DiseaseCompletedNCT01261286Phase 1
- Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease SubjectsCompletedNCT01258205Phase 1
- Chondroitin Sulfate for Crohn's DiseaseWithdrawnNCT01245088Phase 1/2
- Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel DiseaseStatus unknownNCT01244386
- Registry of Pediatric Patients Diagnosed With Crohn's Disease in BelgiumCompletedNCT01241058
- The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease PatientsCompletedNCT01235325Phase 4
- Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's DiseaseCompletedNCT01233960Phase 3
- Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's DiseaseCompletedNCT01233570Phase 2
- Evaluation of Small Bowel Colon Capsule for Bowel Visualization in Crohn's Disease PatientsCompletedNCT01233310
- Green Tea in Crohn's DiseaseStatus unknownNCT01231217Not applicable
- Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)CompletedNCT01218360
- Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's DiseaseCompletedNCT01215890Phase 4
- Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's DiseaseCompletedNCT01203631Phase 2
- Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's DiseaseTerminatedNCT01203254Phase 4
- Vitamin D in Pediatric Crohn's DiseaseCompletedNCT01187459Phase 4
- Evaluation of the Applicability of the CDEIS to Data Obtained by the Colonic Capsule Endoscopy in Crohn DiseaseCompletedNCT01183845Phase 4